- Home
- CIX vs ITOS Comparison
CIX vs ITOS Comparison
Compare CIX & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIX
- ITOS
- Stock Information
- Founded
- CIX 1993
- ITOS 2011
- Country
- CIX United States
- ITOS United States
- Employees
- CIX N/A
- ITOS N/A
- Industry
- CIX Industrial Machinery/Components
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CIX Consumer Discretionary
- ITOS Health Care
- Exchange
- CIX Nasdaq
- ITOS Nasdaq
- Market Cap
- CIX 301.8M
- ITOS 381.2M
- IPO Year
- CIX 1998
- ITOS 2020
- Fundamental
- Price
- CIX $25.80
- ITOS $10.16
- Analyst Decision
- CIX
- ITOS Hold
- Analyst Count
- CIX 0
- ITOS 6
- Target Price
- CIX N/A
- ITOS $10.60
- AVG Volume (30 Days)
- CIX 5.7K
- ITOS 914.0K
- Earning Date
- CIX 08-05-2025
- ITOS 08-07-2025
- Dividend Yield
- CIX 4.63%
- ITOS N/A
- EPS Growth
- CIX N/A
- ITOS N/A
- EPS
- CIX 1.46
- ITOS N/A
- Revenue
- CIX $148,242,000.00
- ITOS $35,000,000.00
- Revenue This Year
- CIX N/A
- ITOS N/A
- Revenue Next Year
- CIX N/A
- ITOS N/A
- P/E Ratio
- CIX $17.75
- ITOS N/A
- Revenue Growth
- CIX N/A
- ITOS 177.89
- 52 Week Low
- CIX $17.89
- ITOS $4.80
- 52 Week High
- CIX $36.10
- ITOS $18.13
- Technical
- Relative Strength Index (RSI)
- CIX 53.98
- ITOS 67.13
- Support Level
- CIX $22.81
- ITOS $9.95
- Resistance Level
- CIX $28.11
- ITOS $10.20
- Average True Range (ATR)
- CIX 1.08
- ITOS 0.16
- MACD
- CIX 0.23
- ITOS -0.10
- Stochastic Oscillator
- CIX 56.42
- ITOS 84.75
About CIX CompX International Inc.
Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's operating segment includes Security Products and Marine Components. The company generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Its geographical segments are the United States, Canada, Mexico, and others, of which the United States accounts for the vast majority of revenue.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.